Brief: Relief Therapeutics Receives FDA Response To Qidp Request For Rlf-Td011

MindMaze Therapeutics Holding SA

20/06/2025 06:03

June 20 (Reuters) - Relief Therapeutics Holding SA RLFB.S:

RELIEF THERAPEUTICS RECEIVES FDA RESPONSE TO QIDP REQUEST FOR RLF-TD011

RELIEF THERAPEUTICS HOLDING SA - FDA SAYS RLF-TD011 DOES NOT MEET QIDP CRITERIA

RELIEF THERAPEUTICS HOLDING SA - EXPECTS FDA'S WRITTEN RESPONSES IN COMING WEEKS

RELIEF THERAPEUTICS HOLDING SA - HOLDS CONSTRUCTIVE PRE-IND MEETING WITH FDA

Source text: ID:nEQ72BHZca

Further company coverage: RLFB.S

 ((Reuters.Briefs@thomsonreuters.com;))